Literature DB >> 11382430

Dynamised cast management of Achilles tendon ruptures.

C P Roberts1, S Palmer, A Vince, L J Deliss.   

Abstract

Non-operative treatment of closed ruptures of the Achilles tendon within 48 h of injury has been shown to produce results comparable with surgical treatment [1,2]. We report 49 patients treated using a dynamised cast, with a mean follow-up of 42 months, in which there has been only one case of re-rupture. A total of 33 patients were reviewed clinically and measurements revealed a mean calf circumference deficit of 1 cm and a mean functional range of ankle motion deficit of 3 degrees and plantar-flexion strength of 81-90%, when compared with the contra-lateral uninjured limb. Early mobilisation of the injured Achilles tendon using a dynamised cast has produced a re-rupture rate and functional recovery that compare favourably with previously published results for patients treated operatively. Non-operative management, in this way, is well tolerated by patients and is of low cost.

Entities:  

Mesh:

Year:  2001        PMID: 11382430     DOI: 10.1016/s0020-1383(00)00195-9

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  3 in total

Review 1.  Management of achilles tendon injury: A current concepts systematic review.

Authors:  Vivek Gulati; Matthew Jaggard; Shafic Said Al-Nammari; Chika Uzoigwe; Pooja Gulati; Nizar Ismail; Charles Gibbons; Chinmay Gupte
Journal:  World J Orthop       Date:  2015-05-18

Review 2.  Defining Components of Early Functional Rehabilitation for Acute Achilles Tendon Rupture: A Systematic Review.

Authors:  Jennifer A Zellers; Marianne Christensen; Inge Lunding Kjær; Michael Skovdal Rathleff; Karin Grävare Silbernagel
Journal:  Orthop J Sports Med       Date:  2019-11-25

3.  Acute Achilles tendon rupture: minimally invasive surgery versus non operative treatment, with immediate full weight bearing. Design of a randomized controlled trial.

Authors:  Roderik Metz; Gino Mmj Kerkhoffs; Egbert-Jan Mm Verleisdonk; Geert J van der Heijden
Journal:  BMC Musculoskelet Disord       Date:  2007-11-06       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.